-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] In recent years, traditional Chinese medicine has become more and more popular in the international mark.
It is understood that under this background, the export value of Chinese herbal medicines and Chinese medicine products in many places has increased significantly this ye.
Statistics show that in April 2022, the export volume of Chinese herbal medicines and Chinese patent medicines in China reached 11,900 tons, a year-on-year increase of 0%; from January to April, the cumulative export volume of Chinese herbal medicines and Chinese patent medicines in China was 44,800 tons, a year-on-year increase of
In the context of the overall increase in the export volume of Chinese herbal medicines and Chinese patent medicines, the value of export goods in many places has also increased significant.
For example, according to customs statistics, in the first quarter of this year, the total import and export value of Chinese medicinal materials and Chinese patent medicines in Bozhou City was 140 million yuan, a decrease of
Among them, the export was 120 million yuan, an increase of 8%, accounting for 72% of the total export value of Chinese herbal medicines and Chinese patent medicines in Anhui Provin.
From the perspective of export markets, South Korea, Vietnam and Taiwan are the top three export destination countries (regions), with exports of 7588 million yuan, 1896 million yuan and 1265 million yuan respectively, an increase of 14% to South Kor.
Exports to RCEP countries amounted to 100 million yuan, a year-on-year increase of
From the perspective of export varieties, the export scale of Rehmannia glutinosa and licorice is relatively large, with exports of 1573 million yuan and 579 million yuan respective.
In addition to the first quarter of this year, in 2021, Bozhou's exports of Chinese herbal medicines and Chinese patent medicines have reached 15,000 tons, worth 510 million yuan, accounting for 62% of the total export value of Chinese herbal medicines in Anhui Provin.
Among them, the export of Chinese medicinal materials to the EU was 231 million yuan, a year-on-year increase of 8
According to Bozhou's "14th Five-Year Plan", by 2025, the scale of the city's traditional Chinese medicine industry will exceed 200 billion yuan, and the total volume of traditional Chinese medicine trade will exceed 120 billion yu.
development opportuniti.
According to statistics, in the first quarter of this year, Anqing City has also exported Chinese medicinal materials worth 248 million yu.
It is worth mentioning that, in order to further help enterprises and increase export volume, Anqing Customs is issuing certificates of origin for exported Chinese medicinal materials to help enterprises enjoy preferential tariffs and improve their competitiveness in the international mark.
At the same time, relevant departments in Anqing are still optimizing business processes, providing appointment inspection services, and inspections and inspections as they are reported and releas.
Go abro.
It can be clearly seen from the above that with the continuous support and promotion of the traditional Chinese medicine industry from the state to the locality, as well as the continuous improvement of the acceptance of traditional Chinese medicine in overseas markets, the export of Chinese medicinal materials and traditional Chinese medicine products in China is continuing to grow, and new markets are also constantly increasi.
Under developme.
At the same time, in recent years, a number of traditional Chinese medicine companies have also obtained the priority to enter the mainstream pharmaceutical consumer markets in Europe and the United States through active application for certification, and have achieved initial resul.
It is reported that many traditional Chinese medicine companies have registered their products in Singapore, Cuba, Vietnam, the United Arab Emirates, Russia and other countri.
However, it should be noted that at present, Chinese herbal medicines and Chinese medicine products are still mainly consumed by Chinese circles abroad, and the growth of market capacity is limit.
In order to further open up the market, relevant enterprises also need to combine factors such as the demand for traditional Chinese medicine and the pharmacological properties of traditional Chinese medicine, and actively develop traditional Chinese medicine products that meet the people of the wor.
In addition, the high-quality and standardized development of the traditional Chinese medicine industry will also be a crucial step in promoting the internationalization of traditional Chinese medicine and gaining more international recogniti.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
It is understood that under this background, the export value of Chinese herbal medicines and Chinese medicine products in many places has increased significantly this ye.
Statistics show that in April 2022, the export volume of Chinese herbal medicines and Chinese patent medicines in China reached 11,900 tons, a year-on-year increase of 0%; from January to April, the cumulative export volume of Chinese herbal medicines and Chinese patent medicines in China was 44,800 tons, a year-on-year increase of
In the context of the overall increase in the export volume of Chinese herbal medicines and Chinese patent medicines, the value of export goods in many places has also increased significant.
For example, according to customs statistics, in the first quarter of this year, the total import and export value of Chinese medicinal materials and Chinese patent medicines in Bozhou City was 140 million yuan, a decrease of
Among them, the export was 120 million yuan, an increase of 8%, accounting for 72% of the total export value of Chinese herbal medicines and Chinese patent medicines in Anhui Provin.
From the perspective of export markets, South Korea, Vietnam and Taiwan are the top three export destination countries (regions), with exports of 7588 million yuan, 1896 million yuan and 1265 million yuan respectively, an increase of 14% to South Kor.
Exports to RCEP countries amounted to 100 million yuan, a year-on-year increase of
From the perspective of export varieties, the export scale of Rehmannia glutinosa and licorice is relatively large, with exports of 1573 million yuan and 579 million yuan respective.
In addition to the first quarter of this year, in 2021, Bozhou's exports of Chinese herbal medicines and Chinese patent medicines have reached 15,000 tons, worth 510 million yuan, accounting for 62% of the total export value of Chinese herbal medicines in Anhui Provin.
Among them, the export of Chinese medicinal materials to the EU was 231 million yuan, a year-on-year increase of 8
According to Bozhou's "14th Five-Year Plan", by 2025, the scale of the city's traditional Chinese medicine industry will exceed 200 billion yuan, and the total volume of traditional Chinese medicine trade will exceed 120 billion yu.
development opportuniti.
According to statistics, in the first quarter of this year, Anqing City has also exported Chinese medicinal materials worth 248 million yu.
It is worth mentioning that, in order to further help enterprises and increase export volume, Anqing Customs is issuing certificates of origin for exported Chinese medicinal materials to help enterprises enjoy preferential tariffs and improve their competitiveness in the international mark.
At the same time, relevant departments in Anqing are still optimizing business processes, providing appointment inspection services, and inspections and inspections as they are reported and releas.
Go abro.
It can be clearly seen from the above that with the continuous support and promotion of the traditional Chinese medicine industry from the state to the locality, as well as the continuous improvement of the acceptance of traditional Chinese medicine in overseas markets, the export of Chinese medicinal materials and traditional Chinese medicine products in China is continuing to grow, and new markets are also constantly increasi.
Under developme.
At the same time, in recent years, a number of traditional Chinese medicine companies have also obtained the priority to enter the mainstream pharmaceutical consumer markets in Europe and the United States through active application for certification, and have achieved initial resul.
It is reported that many traditional Chinese medicine companies have registered their products in Singapore, Cuba, Vietnam, the United Arab Emirates, Russia and other countri.
However, it should be noted that at present, Chinese herbal medicines and Chinese medicine products are still mainly consumed by Chinese circles abroad, and the growth of market capacity is limit.
In order to further open up the market, relevant enterprises also need to combine factors such as the demand for traditional Chinese medicine and the pharmacological properties of traditional Chinese medicine, and actively develop traditional Chinese medicine products that meet the people of the wor.
In addition, the high-quality and standardized development of the traditional Chinese medicine industry will also be a crucial step in promoting the internationalization of traditional Chinese medicine and gaining more international recogniti.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
